[Source: Research & Innovation] Finnish firm Mobidiag has received a EUR 25-million European Investment Bank (EIB) loan to accelerate development and commercialisation of its fast, life-saving tests for small laboratories. The support, provided under the European Fund for Strategic Investments, adds to a previous EUR 15 million EIB loan extended under the InnovFin Infectious Diseases Finance Facility under the EU's Horizon 2020 programme.
from EUROPA - Syndicated Research News Feed http://bit.ly/2ICiGVt
via IFTTT
No comments:
Post a Comment